Prosensa Announces 3rd Quarter 2014 Financial Results and Recent Corporate Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Prosensa Holding N.V. (RNA) Reports Q3 Loss of EUR 0.29/Share
November 17, 2014 7:10 AM ESTProsensa Holding N.V. (NASDAQ: RNA) reported Q3 EPS of (0.29), versus (0.12) reported last year.
Recent Corporate Highlights
Drisapersen Development Program
On September 17, we announced that a staged program of re-dosing had commenced, with the first patients re-dosed in the United States. The re-dosing program in North America will include up to 72 patients across 14 sites... More